Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
7.59
-0.29 (-3.68%)
At close: Mar 28, 2025, 4:00 PM
7.47
-0.12 (-1.58%)
After-hours: Mar 28, 2025, 7:22 PM EDT
RCKT's stock price has decreased by -72.15% in the past year and price targets may not have had time to catch up.
Rocket Pharmaceuticals Analyst Ratings
Total Analysts
10
Consensus Rating
Strong Buy
Price Target
$44.10
Upside
+481.03%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BMO Capital | BMO Capital | Buy Initiates $50 | Buy | Initiates | $50 | +558.76% | Mar 12, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $51 → $52 | Buy | Maintains | $51 → $52 | +585.11% | Mar 3, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $29 → $15 | Hold | Maintains | $29 → $15 | +97.63% | Mar 3, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $39 → $36 | Strong Buy | Maintains | $39 → $36 | +374.31% | Mar 3, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $62 → $54 | Strong Buy | Maintains | $62 → $54 | +611.46% | Feb 28, 2025 |
| Needham | Needham | Strong Buy Maintains $52 → $42 | Strong Buy | Maintains | $52 → $42 | +453.36% | Feb 28, 2025 |
| Jefferies | Jefferies | Strong Buy Initiates $29 | Strong Buy | Initiates | $29 | +282.08% | Dec 18, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $39 | Strong Buy | Maintains | $39 | +413.83% | Nov 19, 2024 |
| Leerink Partners | Leerink Partners | Buy Maintains $46 → $44 | Buy | Maintains | $46 → $44 | +479.71% | Nov 19, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $65 | Buy | Reiterates | $65 | +756.39% | Nov 19, 2024 |
| Needham | Needham | Strong Buy Reiterates $52 | Strong Buy | Reiterates | $52 | +585.11% | Nov 19, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $62 | Strong Buy | Maintains | $62 | +716.86% | Nov 18, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $62 | Strong Buy | Maintains | $62 | +716.86% | Nov 11, 2024 |
| Needham | Needham | Strong Buy Reiterates $52 | Strong Buy | Reiterates | $52 | +585.11% | Nov 8, 2024 |
| Scotiabank | Scotiabank | Buy Initiates $50 | Buy | Initiates | $50 | +558.76% | Oct 16, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $38 | Strong Buy | Maintains | $38 | +400.66% | Sep 30, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.